- Focused on Work, Needed at Home: A Federal Caregiving Policy Might Help
- States ranked by share of healthcare workers
- CMS finalizes framework for Medicaid work rules: 8 things to know
- Ochsner exec joins UMC New Orleans as COO
- Boston Children’s saves $7M, 60K hours with OpenAI
- From Calls to Clicks: Where Patient Experience Meets Throughput
- Maternal mental health grades by state
- 6 unique Rural Health Transformation fund proposals
- Illinois hospital taps CFO
- UHS Texas hospital taps new CFO
- Student debt rewrites oral surgery succession plans
- Health systems aren’t just killing more AI projects — they’re starting fewer
- Centerstone begins CEO transition
- 720 hospitals at risk of closure, by state
- Nonprofit opens dental center in Maine with $2M in funding
- 16 new behavioral health study findings to know
- AdventHealth relocates cardiology practice in Georgia
- Anesthesia under fire: 3 recent legal, policy fights
- Former lab CEO, physician to pay $1.2M+ to settle kickback scheme allegations
- MDMA-assisted therapy, explained
- PDS Health continues de novo growth with 5 new practices
- Commission Statement on the Passing of Former General Counsel David Becker
- 5 highest-paying states for specialty dentists
- Virginia oral surgery center opens 6th office
- New York health system to shutter ASC amid declining patient volume
- North Carolina projects $1B autism therapy spending: 6 notes
- 3 dental leadership moves to know
- CMS outlines national framework to support rollout of Medicaid work requirements
- The rise of the physician side hustle
- How NYU Langone is helping modernize a decades-old GI surgery tool
- The 6 highest-paying practice settings for ophthalmologists
- Dentists’ pay dipped the most in these 10 states
- Where the largest DSOs stand halfway through 2026
- ASCA elects new board president
- 7 physician practices shut their doors in 1 month
- Physician groups welcome IDR rule changes
- Indiana dental office suffers data breach affecting 5,900 individuals
- Your Surprise Medical Bill May Be Gone — But Your Premiums Could Still Spike
- New Connecticut private equity law bans hospital sale-leasebacks
- 17 dentists making headlines
- Mental health ED visits on the rise in 2026: 5 things to know
- How 4 systems are breaking the ED boarding cycle
- CDC: 2025's uninsured rate stayed flat at 8.3%
- Trump signs off on HHS overhaul of childhood vaccine schedule with new executive order
- Trump signs off on HHS overhaul of childhood vaccine schedule with new executive order
- Short-Term Fasting Could Boost Chemo Response in Ovarian Cancer, Study Suggests
- MedTech In Focus: AI impact in healthcare
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- Patients with treatment-resistant depression are costing Medicare big
- Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative
- How HER2 biology is shaping next-generation cancer treatment
- Workout Habits May Protect Against Inherited Heart Problems
- Childhood Lying Is Normal and Rarely Signals Behavioral Concerns, Study Says
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- After Her Bout of Amnesia, A $59,000 Billing Dispute Wouldn't Go Away
- Weed Linked To Higher Testosterone Levels In Young Men
- Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump’s Health Cuts
- Baffling. Frustrating. Frightening. What It’s Like To Be Sued Over Medical Debt.
- Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
- ViiV Healthcare launches ‘PrEP Wisdom’ campaign to boost awareness of long-acting HIV prevention meds
- Noom launches at-home biomarker test kit for metabolic health monitoring
- ASCO: AstraZeneca's Imfinzi, Imjudo duo shines in earlier-stage liver cancer
- CVS, Walgreens and Walmart defeat opioid lawsuit brought by Florida hospitals
- ASCO: Sac-TMT’s massive phase 3 program has a jarring gap. Does Merck plan to close it?
- ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
- ASCO: J&J breaks the prostate cancer treatment mold with fresh Erleada ph. 3 win
- ASCO: Revolution Medicines confident in RAS leadership as rivals square up
- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: Lilly ties Retevmo to ‘dramatic’ outcomes in early-stage lung cancer with rare RET biomarker
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- Enzo Health launches agentic EHR for home health agencies
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- Why direct-to-patient is the future of pharma access
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- Cleveland Clinic, Aspira Women’s Health partner on AI-powered women's health diagnostics
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Remarks at the Stanford Rock Center for Corporate Governance
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
Sally Pipes pans the current trend of states creating their own health care insurance plans:
https://www.newsmax.com/sallypipes/public-plans-healthcare/2023/05/26/id/1121340/
State Public Plans No Blueprint for Affordable Healthcare
By Sally Pipes - 26 May 2023A divided Congress has prevented "Medicare for All" from taking off. So progressive activists have turned their attention to the states. Several have launched "public options," health plans chartered by the state to compete against private insurers.
The results have not been impressive. People are not opting for public option plans, so state governments are beginning to rig insurance markets in their favor. Such intervention reveals that state officials intend for their public options to eventually become the only option for health insurance — at great cost to taxpayers and patients.
Washington and Colorado were among the earliest states to launch public option plans. They encountered roadblocks from the get-go. Washington's plan, Cascade Select, had fewer than 800 individuals sign up during its first year.
In its second year, Cascade Select attracted 6,335 enrollees — just 3% of all exchange enrollees in Washington. Though they were promised low prices, participants have faced monthly premiums of over $400 — almost 30% higher than private insurance premiums in some parts of the state.
Washington's public option initially struggled to gain traction because providers balked at joining its network. That's because the public plan pays providers no more than 160% of Medicare's rates. Private plans pay an average of 174% of Medicare's rates. In 2021, public option plans were only available in 19 of the state's 39 counties; a year later, that number was up to 25 of 39.
State officials were unsatisfied with these marks. So they started threatening providers and throwing taxpayer money at the problem. Hospitals are now required to accept at least one public option plan. The state also provides additional premium subsidies on top of those from the federal government for people making less than 250% of the federal poverty level — $75,000 for a family of four.
These state-enforced advantages have helped Cascade Select. Public plans are available in 34 of 39 counties, and 27,000 people have signed up — about 11% of exchange enrollees. But despite all this state backing, public plans are still not the lowest-cost option in nine counties where they're available.
More state aid may be coming Cascade Select's way. Some policymakers are floating lower reimbursement rates for providers to try to reduce premiums further. Given the requirement to participate, they may just have to take what the government gives them.
Colorado has also failed to meet expectations. Only 25,000 of the state's 5.8 million residents were enrolled in public option plans this year. And just one insurer will be able to meet the requirement that they reduce premiums 10% next year, relative to 2021 levels.
State officials and consumer advocates are hinting that more price caps may be coming for public option plans. Those may be politically popular. But they risk driving insurers out of the state's market.
Public-option enthusiasts in other states are ignoring Washington's and Colorado's cautionary tales — and forging ahead with doomed public plans of their own.
Nevada will just force hospitals and insurers to participate in their public option program, which starts in 2026. In Minnesota, legislators are considering letting people "buy in" to the state's Medicaid program. New Mexico is exploring something similar. Given that Medicaid pays providers much less than private plans do, this idea is a recipe for higher premiums in the private market.
Lawmakers in Connecticut are struggling with the failure of the Connecticut Partnership Plan, a public option that allowed municipal workers to join the health plan available to state employees. CPP ended fiscal 2022 with a shortfall of more than $54 million — not exactly an advertisement for putting the state in charge of yet more people's health insurance.
Two professors at the University of California, Berkeley, have been stumping for a new public option they call "Golden Choice." Healthcare providers would accept some level of risk for the costs associated with treating a group of patients. In exchange, they would receive a risk-adjusted monthly payment for each enrollee.
The professors claim the new offering would yield lower costs for patients and save the healthcare system hundreds of millions of dollars per year.
This model, of course, incentivizes providers to skimp on care. After all, the less they do for patients, the more of the monthly payments they keep as profits. Patients won't like that trade-off.
States appear willing to ruin their insurance markets in order to keep their public options from failing. In this way, a public option represents a stepping-stone approach to single-payer health care, where the government is the only provider.
Sally C. Pipes is president, CEO, and the Thomas W. Smith fellow in healthcare policy at the Pacific Research Institute. Her latest book is "False Premise, False Promise: The Disastrous Reality of Medicare for All," (Encounter Books 2020). Follow her on Twitter @sallypipes.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















